Pneumococcal vaccination in elderly care facilities in Japan: A cross-sectional, web-based survey
This study evaluated pneumococcal vaccination status using evaluable data collected from 445 of 1,313 managing directors of elderly care facilities in Japan through an online survey (September 5, 2022-November 25, 2022; UMIN000048747); comparisons were made with the influenza (2021–2022 vaccination...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2025.2461814 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1825206508850249728 |
---|---|
author | Youngju Kim Hironori Taniguchi Kotoba Okuyama Junpei Kamimoto Kenji Kawakami |
author_facet | Youngju Kim Hironori Taniguchi Kotoba Okuyama Junpei Kamimoto Kenji Kawakami |
author_sort | Youngju Kim |
collection | DOAJ |
description | This study evaluated pneumococcal vaccination status using evaluable data collected from 445 of 1,313 managing directors of elderly care facilities in Japan through an online survey (September 5, 2022-November 25, 2022; UMIN000048747); comparisons were made with the influenza (2021–2022 vaccination only) and coronavirus disease 2019 (COVID-19) vaccination status. Among facilities who kept pneumococcal vaccination records (n = 42), the mean pneumococcal vaccination rate was 31.1%, with the rate being higher for the influenza (93.1%; n = 234) and COVID-19 (94.3%; n = 285) vaccines. Overall, excluding facilities that answered that the corresponding vaccine status at their sites was unknown, the percentage of facilities with high vaccination rates (80% to 100%) was substantially higher for the influenza (80.5%; 351/436) and COVID-19 (89.6%; 396/442) vaccines than for the pneumococcal vaccine (6.5%; 24/370). Multivariable analysis showed that major factors associated with a high pneumococcal vaccination rate (≥15%) were “managing director’s willingness to recommend” and “pneumococcal vaccination request from the residents.” The most common reason for their willingness to recommend the pneumococcal vaccine was that it is an effective disease prevention strategy (83.3%; 65/78) and for their unwillingness to recommend the pneumococcal vaccine was the inability to understand the effectiveness of the vaccine (43.6%; 17/39). In conclusion, there is a need to improve pneumococcal vaccination rates in elderly care facilities in Japan. Strategies such as increasing awareness and encouraging pneumococcal vaccine recommendation among managing directors, especially for residents not eligible for the national subsidy program, and providing regular training on the pneumococcal vaccine for staff and residents are required. |
format | Article |
id | doaj-art-b81c0d52fbc94a2fa35d747373b09f0b |
institution | Kabale University |
issn | 2164-5515 2164-554X |
language | English |
publishDate | 2025-12-01 |
publisher | Taylor & Francis Group |
record_format | Article |
series | Human Vaccines & Immunotherapeutics |
spelling | doaj-art-b81c0d52fbc94a2fa35d747373b09f0b2025-02-07T08:49:03ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2025-12-0121110.1080/21645515.2025.2461814Pneumococcal vaccination in elderly care facilities in Japan: A cross-sectional, web-based surveyYoungju Kim0Hironori Taniguchi1Kotoba Okuyama2Junpei Kamimoto3Kenji Kawakami4Medical Affairs, MSD K. K., Tokyo, JapanMedical Affairs, MSD K. K., Tokyo, JapanMedical Affairs, MSD K. K., Tokyo, JapanMedical Affairs, MSD K. K., Tokyo, JapanDepartment of Internal Medicine, NTT East Izu Hospital, Shizuoka, JapanThis study evaluated pneumococcal vaccination status using evaluable data collected from 445 of 1,313 managing directors of elderly care facilities in Japan through an online survey (September 5, 2022-November 25, 2022; UMIN000048747); comparisons were made with the influenza (2021–2022 vaccination only) and coronavirus disease 2019 (COVID-19) vaccination status. Among facilities who kept pneumococcal vaccination records (n = 42), the mean pneumococcal vaccination rate was 31.1%, with the rate being higher for the influenza (93.1%; n = 234) and COVID-19 (94.3%; n = 285) vaccines. Overall, excluding facilities that answered that the corresponding vaccine status at their sites was unknown, the percentage of facilities with high vaccination rates (80% to 100%) was substantially higher for the influenza (80.5%; 351/436) and COVID-19 (89.6%; 396/442) vaccines than for the pneumococcal vaccine (6.5%; 24/370). Multivariable analysis showed that major factors associated with a high pneumococcal vaccination rate (≥15%) were “managing director’s willingness to recommend” and “pneumococcal vaccination request from the residents.” The most common reason for their willingness to recommend the pneumococcal vaccine was that it is an effective disease prevention strategy (83.3%; 65/78) and for their unwillingness to recommend the pneumococcal vaccine was the inability to understand the effectiveness of the vaccine (43.6%; 17/39). In conclusion, there is a need to improve pneumococcal vaccination rates in elderly care facilities in Japan. Strategies such as increasing awareness and encouraging pneumococcal vaccine recommendation among managing directors, especially for residents not eligible for the national subsidy program, and providing regular training on the pneumococcal vaccine for staff and residents are required.https://www.tandfonline.com/doi/10.1080/21645515.2025.2461814COVID-19 vaccinationelderly care facility residentsinfluenza vaccinationJapanpneumococcal vaccinationvaccination rate |
spellingShingle | Youngju Kim Hironori Taniguchi Kotoba Okuyama Junpei Kamimoto Kenji Kawakami Pneumococcal vaccination in elderly care facilities in Japan: A cross-sectional, web-based survey Human Vaccines & Immunotherapeutics COVID-19 vaccination elderly care facility residents influenza vaccination Japan pneumococcal vaccination vaccination rate |
title | Pneumococcal vaccination in elderly care facilities in Japan: A cross-sectional, web-based survey |
title_full | Pneumococcal vaccination in elderly care facilities in Japan: A cross-sectional, web-based survey |
title_fullStr | Pneumococcal vaccination in elderly care facilities in Japan: A cross-sectional, web-based survey |
title_full_unstemmed | Pneumococcal vaccination in elderly care facilities in Japan: A cross-sectional, web-based survey |
title_short | Pneumococcal vaccination in elderly care facilities in Japan: A cross-sectional, web-based survey |
title_sort | pneumococcal vaccination in elderly care facilities in japan a cross sectional web based survey |
topic | COVID-19 vaccination elderly care facility residents influenza vaccination Japan pneumococcal vaccination vaccination rate |
url | https://www.tandfonline.com/doi/10.1080/21645515.2025.2461814 |
work_keys_str_mv | AT youngjukim pneumococcalvaccinationinelderlycarefacilitiesinjapanacrosssectionalwebbasedsurvey AT hironoritaniguchi pneumococcalvaccinationinelderlycarefacilitiesinjapanacrosssectionalwebbasedsurvey AT kotobaokuyama pneumococcalvaccinationinelderlycarefacilitiesinjapanacrosssectionalwebbasedsurvey AT junpeikamimoto pneumococcalvaccinationinelderlycarefacilitiesinjapanacrosssectionalwebbasedsurvey AT kenjikawakami pneumococcalvaccinationinelderlycarefacilitiesinjapanacrosssectionalwebbasedsurvey |